Provided by Tiger Trade Technology Pte. Ltd.

CUTIA-B

1.020
-0.080-7.27%
Volume:960.80K
Turnover:993.19K
Market Cap:380.46M
PE:-0.99
High:1.280
Open:1.030
Low:1.000
Close:1.100
52wk High:9.190
52wk Low:0.740
Shares:373.00M
HK Float Shares:373.00M
Volume Ratio:0.58
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.030
ROE:-38.30%
ROA:-14.05%
PB:0.46
PE(LYR):-0.99
PS:0.98

Loading ...

Have Insiders Sold Cutia Therapeutics Shares Recently?

Simply Wall St.
·
6 hours ago

Cutia Therapeutics to Launch Up to 30 Million Yuan Share Buyback

MT Newswires Live
·
Yesterday

Cutia Therapeutics Announces RMB30.00 Million Share Repurchase Programme for 4Q26

Bulletin Express
·
Yesterday

CUTIA-B (02487) Plans to Execute a Share Buyback Program

Stock News
·
Yesterday

Cutia Therapeutics - to Implement Share Repurchase Program from Oct 2 to Dec 31, 2026

THOMSON REUTERS
·
Yesterday

Cutia Therapeutics - Maximum Funds for Repurchase Set at RMB30 Mln, up to 36.3 Mln Shares

THOMSON REUTERS
·
Yesterday

CUTIA-B (02487): Lei Lei Appointed as Executive Director

Stock News
·
Yesterday

Cutia Therapeutics - Mr. Huang Yuqing Resigns as Executive Director and CFO Effective 30 September 2026

THOMSON REUTERS
·
Yesterday

CUTIA-B: Lele Zhang Disposes of Shares, Long Position Falls to 7.12%

HK Disclosure
·
Sep 25

CUTIA-B: Lele Zhang Disposes of Shares, Long Position Falls to 7.32%

HK Disclosure
·
Sep 25

Hong Kong Market Movers: CUTIA-B (02487) Climbs Over 3% Following Macau Drug Approval

Stock News
·
Sep 24

Cutia Therapeutics Gets Macao Approval for Topical Finasteride Spray

MT Newswires Live
·
Sep 21

CUTIA-B Receives Macau Regulatory Approval for Topical Finasteride Spray Product

Stock News
·
Sep 21

Cutia Therapeutics: CU-40102 Topical Finasteride Spray Gains Macao Marketing Approval, Complementing China and Hong Kong Clearances

Bulletin Express
·
Sep 21

Cutia Therapeutics - Cu-40102 Obtains Marketing Approval from Macao Pharmaceutical Administration Bureau

THOMSON REUTERS
·
Sep 21

CUTIA-B Records Stable Share Base in August 2026; Confirms Public Float Compliance

Bulletin Express
·
Sep 04

Cutia Therapeutics' Marketing Application for Botox Product Accepted in China

MT Newswires Live
·
Sep 03

Cutia Therapeutics Says China Regulator Accepts CU-20101 Botulinum Toxin BLA for Review

Reuters
·
Sep 03

CUTIA-B's Botulinum Toxin Injection Clears Regulatory Hurdle with NMPA Filing Acceptance

Stock News
·
Sep 03

Cutia Therapeutics’ BLA for CU-20101 Botulinum Toxin Accepted by China’s NMPA

Bulletin Express
·
Sep 03